N-(2-octyl) piperidine

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 哌啶类
• 英文名称: N-(2-octyl) piperidine
• 英文别名: 1-(1-methyl-1-heptyl)-piperidine；1-Octan-2-ylpiperidine；1-octan-2-ylpiperidine
• 化学式: C₁₃H₂₇N
• 分子量: 197.364
• InChiKey: RLOLOYSMJLRUON-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.4
• 重原子数：
  14
• 可旋转键数：
  6
• 环数：
  1.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  3.2
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为产物：
  描述：

  哌啶 、 仲辛醇 在 lithium hydroxide 作用下， 以 neat (no solvent) 为溶剂， 反应 48.0h， 以65%的产率得到N-(2-octyl) piperidine
  参考文献：
  名称：

  An efficient heterogenized palladium catalyst for N-alkylation of amines and α-alkylation of ketones using alcohols

  摘要：

  硅胶支持的钯-NiXantphos复合物是一种高效且高周转的杂化催化剂，可在120-140°C的干净条件下使用醇对胺的N-烷基化和酮的α-烷基化进行催化，遵循氢借位策略。

  DOI：

  10.1039/c5ra07225e

文献信息

• An efficient heterogenized palladium catalyst for N-alkylation of amines and α-alkylation of ketones using alcohols
  作者：Tuan Thanh Dang、Siah Pei Shan、Balamurugan Ramalingam、Abdul Majeed Seayad

  DOI：10.1039/c5ra07225e

  日期：——

  Silica supported palladium–NiXantphos complex is an efficient and high turnover heterogeneous catalyst for N-alkylation of amines and α-alkylation of ketones using alcohols under neat conditions at 120–140 °C following hydrogen borrowing strategy.

  硅胶支持的钯-NiXantphos复合物是一种高效且高周转的杂化催化剂，可在120-140°C的干净条件下使用醇对胺的N-烷基化和酮的α-烷基化进行催化，遵循氢借位策略。
• Salt-Free Synthesis of Tertiary Amines by Ruthenium-Catalyzed Amination of Alcohols
  作者：Annegret Tillack、Dirk Hollmann、Kathleen Mevius、Dirk Michalik、Sebastian Bähn、Matthias Beller

  DOI：10.1002/ejoc.200800671

  日期：2008.10

  The amination of secondary alcohols to give tertiary amines in the presence of different in situ generated ruthenium catalysts has been investigated in detail. By applying a combination of [Ru3(CO)12] and N-phenyl-2-(dicyclohexylphosphanyl)pyrrole as the catalyst, cyclic amines can be alkylated with different alcohols in high yield, whereas aliphatic amines gave transalkylation side products.(© Wiley-VCH

  已经详细研究了在不同的原位生成的钌催化剂存在下仲醇胺化生成叔胺的过程。通过使用 [Ru3(CO)12] 和 N-苯基-2-（二环己基膦酰基）吡咯的组合作为催化剂，环胺可以用不同的醇以高产率进行烷基化，而脂肪胺产生烷基转移副产物。（© Wiley -VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, Germany, 2008)
• An Efficient Palladium-Catalyzed N-Alkylation of Amines Using Primary and Secondary Alcohols
  作者：Tuan Thanh Dang、Balamurugan Ramalingam、Siah Pei Shan、Abdul Majeed Seayad

  DOI：10.1021/cs400799n

  日期：2013.11.1

  PdCl2 in the presence of dppe or Xantphos(t-Bu) as the ligand is found to be an efficient catalyst for the N-alkylation of various primary and cyclic secondary amines using primary alcohols at 90–130 °C under neat conditions. Interestingly, good to excellent yields were achieved when more challenging secondary alcohols were used as alkylating agents at 130–150 °C. The reaction could be easily scaled

  发现在dppe或Xantphos（t -Bu）作为配体的情况下，PdCl 2是使用伯醇在90-130°C的纯净条件下对各种伯和环状仲胺进行N-烷基化的有效催化剂。有趣的是，在130–150°C下使用更具挑战性的仲醇作为烷基化剂时，获得了良好的优良收率。如10毫摩尔规模所示，TON值为900时，收率可高达90％，证明该反应可以轻松扩大规模。
• NOVEL PYRAZOLO[3,4-d]PYRIMIDINE COMPOUND OR SALT THEREOF
  申请人：TAIHO PHARMACEUTICAL CO., LTD.

  公开号：US20170217970A1

  公开（公告）日：2017-08-03

  To provide a novel compound having a HER2 inhibitory effect and having a cytostatic effect. It is also intended to provide a medicament useful in the prevention and/or treatment of a disease involving HER2, particularly, cancer, on the basis of the HER2 inhibitory effect. The present invention provides a compound of formula (I) wherein X, Y, Z 1 , Z 2 , Z 3 , Z 4 , W, n, R 1 , R 2 , and R 3 have meanings as defined in the present specification, or a salt thereof.

  提供一种具有HER2抑制作用和细胞静止作用的新化合物。还旨在提供一种药物，基于HER2抑制作用，可用于预防和/或治疗涉及HER2的疾病，特别是癌症。本发明提供一种具有以下结构的化合物（I），其中X、Y、Z1、Z2、Z3、Z4、W、n、R1、R2和R3的含义如本说明书中定义，或其盐。
• Applications of Substituent Benzyloxy Group Containing Ether Compounds for Preparing Antitumor Drugs
  申请人：SINOCHEM CORPORATION

  公开号：US20170296508A1

  公开（公告）日：2017-10-19

  Disclosed are applications of substituent benzyloxy group containing ether compounds represented by general formula I for preparing antitumor drugs. The definition of the substituent groups in the formula I are provided in the specification. The compounds having general formula I have desirable antitumor activity, particularly, and have excellent activity against leukemia strain HL-60, lung cancer A549, H157, H460, H520, bladder cancer T24, J82, prostate cancer LNCap, PC-3, rectal cancer HCT8, HCT116, RkO and the like.